Direct Peptides score history

Score over time

Every entry newest first

1. November 5, 2026Raised from7.30→to7.43(+0.13)

   Pricing re-checked on 5 November 2026 after the market medians were recalculated with Peptyes added pricing 4.9 to 5.8.

2. November 1, 2026Lowered from7.36→to7.30(-0.06)

   Market medians updated after Bluum Peptides was added pricing 5.3 to 4.9.

3. October 27, 2026Lowered from7.39→to7.36(-0.03)

   Market medians updated after S1Research was added pricing 5.5 to 5.3.

4. October 22, 2026Lowered from7.61→to7.39(-0.22)

   Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: shipping and refunds 9.5 to 8.5, transparency 4.5 to 4.0.

5. October 22, 2026Raised from7.50→to7.61(+0.11)

   Re-scored on 22 October 2026 under version 2 of our published rules. The deduction for verification codes the laboratory could not find was retired: each such certificate now keeps its points for the printed key and earns none for confirmation, and codes on certificates we do not score no longer count. The posted oxytocin certificate prints 9.96 mg where the laboratory's copy prints 4.96 mg, so it now scores 0 instead of carrying a separate deduction. Lab 8.0 to 8.2. Score 7.50 to 7.61.

6. October 22, 2026Lowered from7.61→to7.50(-0.11)

   Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 8.0 to 9.5, pricing 8.3 to 5.5, operating history 2.8 to 3.0.

7. October 22, 2026Lowered from7.72→to7.61(-0.11)

   Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: every listed product was rescored on the same fixed certificate points, with fixed deductions for posted certificate copies that differ from the laboratory's own copy and verification codes the issuing laboratory could not find. Lab 8.2 to 8.0.

8. October 22, 2026Raised from7.50→to7.72(+0.22)

   Lab evidence re-checked on 20 October 2026 under our coverage rule, which counts a listed product with no published certificate as zero in the lab average. Certificates cover 33 of the 33 products we list that the vendor offers for sale. Lab 7.8 to 8.2.

9. October 18, 2026Raised from4.87→to7.50(+2.63)

   Re-audited on 2026-10-18 from the live site and the issuing laboratories. Lab rises from 4.85 to 7.8: the May review found no per-product certificates, while every product now links a current certificate and nearly all Horizon Analytical reports were confirmed on the laboratory's own portal, with accredited full-panel reports for two products. Shipping rises from 5.9 to 8.0 on a published same-day cutoff, tracked USPS shipping, damage and loss replacement and a return route for unopened items, held back by contradictory wording in the general terms. Pricing rises from 4.6 to 8.3 because standard prices now sit at the market median across 33 compounds. Tenure eases from 3.3 to 2.8 because the current store dates from 2025 even though the domain is older. Transparency rises from 3.3 to 4.5 for the verifiable certificate library and a published mailing address, still limited by the absence of a named operating company. Note added 22 October 2026: the two full-panel reports are from Vanguard Laboratory; Vanguard Laboratory's A2LA accreditation does not cover peptide testing, so it is not counted as accredited (check L6).